Surgery combined with dopamine agonists versus dopamine agonists alone in long-term treatment of macroprolactinoma: A retrospective study

Experimental and Clinical Endocrinology and Diabetes

Volumn 106, Issue 3, 1998, Pages 211-216

  Hofle, G ^a   Gasser, R ^a   Mohsenipour, I ^a   Finkenstedt, G ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Dopamine agonist therapy; Hyperprolactinaemia; Macroprolactinoma; Pituitary insufficiency; Pituitary surgery

Indexed keywords

BROMOCRIPTINE MESILATE; DOPAMINE RECEPTOR STIMULATING AGENT; LISURIDE; PROLACTIN; QUINAGOLIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; ENDOCRINE SURGERY; FEMALE; HUMAN; HYPOPHYSIS FUNCTION; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; PROLACTINOMA; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; TUMOR REGRESSION; VISUAL FIELD DEFECT;

EID: 0031848414     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211978     Document Type: Article

References (19)